Side-by-side financials for ALT and AZN. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ALT | AZN |
|---|---|---|
| Market cap | - | $286.27 B |
| US-listed rank | - | #48 |
| Revenue (latest FY) | $41.00K | - |
| Net income (latest FY) | -$88.09M | - |
| Net margin | -214861.0% | - |
| SEC filings | 997 | 1,004 |
Full pages: Altimmune, Inc. and AstraZeneca PLC, or browse the full rankings.